Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
A comprehensive characterization of the tumour microenvironment is lacking in neuroendocrine tumours (NETs), where programmed cell death-1 receptor-ligand (PD-1/PD-L1) inhibitors are undergoing efficacy testing.
Pubmed ID: 32097935
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets Human B7-H1 Phycoerythrin MAb (Clone 130021)
View all literature mentions